Yale Bulletin and Calendar

May 6, 2005|Volume 33, Number 28|Two-Week Issue


BULLETIN HOME

VISITING ON CAMPUS

CALENDAR OF EVENTS

IN THE NEWS

BULLETIN BOARD

CLASSIFIED ADS


SEARCH ARCHIVES

DEADLINES

DOWNLOAD FORMS

BULLETIN STAFF


PUBLIC AFFAIRS HOME

NEWS RELEASES

E-MAIL US


YALE HOME PAGE


Study: Using black cohosh herb can affect outcome of breast cancer therapy

Black cohosh, an herb widely used by breast cancer patients to alleviate hot flashes and other menopausal symptoms, may alter the way that cells respond to drugs commonly used to treat breast cancer, according to a School of Medicine study in the journal Breast Cancer Research and Treatment.

Recent studies have shown that many patients receiving cancer therapy are also self-medicating with complementary and alternative medicines, often without telling their physicians, says the lead researcher, Sara Rockwell, professor of therapeutic radiology and pharmacology.

"Over 30 insurers now cover at least one alternative therapy," she says. "Out-of-pocket spending for complementary and alternative medicines was recently estimated to be $27 billion per year, similar to the out-of-pocket costs for all physician services."

She says the herb is being widely used by and recommended to breast cancer patients who are experiencing menopausal symptoms due to removal from hormone replacement therapy or to the effects of their therapy.

In this research, Rockwell and her team used a widely studied mouse breast cancer cell line to see whether commercially available extracts of black cohosh altered the response of cancer cells to radiation and to four drugs commonly used in cancer therapy.

The black cohosh increased cell killing by two of the drugs, decreased the effectiveness of one drug and did not alter the effects of radiation or a fourth drug, notes Rockwell. Why each agent responded differently needs to be studied further, she says, but enough is known about the herb's effects on cancer cells to caution patients about using it and other over the counter agents without consulting their physicians.

"Our studies caution that black cohosh should not be considered to be a harmless herb that is inconsequential to the health of cancer patients or to the outcome of conventional cancer therapy," Rockwell says.

Co-authors included Yanfeng Liu and Susan Higgins, both from the Department of Therapeutic Radiology at Yale. The research was supported by a grant from the Donaghue Women's Health Investigator Program at Yale. Further studies are in progress with support from the National Cancer Institute.

-- By Jacqueline Weaver


T H I SW E E K ' SS T O R I E S

Renowned Harvard scholar named dean of Yale SOM

F&ES group gets lessons in global, local activism during Kenya trip

Champion archer aims to achieve state of grace when wielding her bow

Report details University's progress on environmental issues

'Mugsy' proves to be top dog in Handsome Dan competition

Whistler works, recent acquisitions showcased in exhibitions

Scholar of womanist theology and expert on the art of preaching . . .

Researchers illuminate how bacteria becomes resistant to antibiotics

YALE LIBRARY NEWS

Grants from Seaver Institute support medical and library projects

African-American women report wider range of menopausal symptoms

International array of scholars to discuss 'Culture in the World'

Events to examine the risks and benefits of biopharming

MEDICAL SCHOOL NEWS

Awards to two faculty members support improved race relations

Engineer wins grant for research in nanotechnology

Painting at the Y

IN MEMORIAM

Yale Books in Brief

Campus Notes

From sneakers to playgrounds